Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 20/20 | 0.64 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL382292 | 0.91 | ADORA1 (0.76) | ADORA1ADORA2BADORA2AADORA3SLC6A3 | |
| SCHEMBL12503216 | 0.87 | ADORA1 (0.64) | ADORA1ADORA2BADORA2AADORA3 | |
| SCHEMBL381576 | 0.84 | ADORA1 (0.63) | ADORA1ADORA2BADORA2AADORA3SLC6A3 | |
| SCHEMBL245416 | 0.83 | ADORA1 (0.86) | ADORA1ADORA2BADORA2AADORA3 | |
| SCHEMBL245503 | 0.83 | ADORA1 (0.72) | ADORA1ADORA2B | |
| SCHEMBL244063 | 0.83 | ADORA1 (0.77) | ADORA1ADORA2BADORA2A | |
| SCHEMBL12910806 | 0.82 | ADORA1 (0.62) | ADORA1ADORA2BADORA2AADORA3SLC6A3 | |
| SCHEMBL10148609 | 0.81 | ADORA1 (0.61) | ADORA1ADORA2BADORA2ASLC6A3 | |
| SCHEMBL8034134 | 0.80 | ADORA1 (0.63) | ADORA1ADORA2BADORA2AADORA3SLC6A3 | |
| SCHEMBL1421671 | 0.80 | ADORA1 (0.61) | ADORA1ADORA2BADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2588454-A1 | SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF | Bayer Intellectual Property GmbH (DE) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012000945-A1 | SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-01-05 | — | — | WO | disclosed |